Dr. Faizul Haque, MD

Dr. Haque practices at John Muir Medical Center - Walnut C - Imaging - HOPD in Walnut Creek, California.

Dr. Haque's NPI, 1609952597, was assigned on October 31, 2006. Dr. Haque graduated from Penn State College of Medicine in 2003. Dr. Haque holds California license C54874.

Dr. Haque's primary practice is John Muir Medical Center - Walnut C - Imaging - HOPD, at 1450 Treat Blvd, Walnut Creek, CA 94597.

Dr. Haque's primary practice is John Muir Medical Center - Walnut C - Imaging - HOPD in Walnut Creek, California. Dr. Haque is also affiliated with John Muir Medical Center, Walnut Creek. The medical group on file is John Muir Health. Dmand AI also links Dr. Haque to 4 more hospitals, 3 group practices and clinics and 3 medical groups, each named with a free account. Dr. Haque's employer is on file too: a hospital.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Haque practices, 9 sites in all. Vendor and product names are available with a free account.

Cardiovascular disease is Dr. Haque's primary specialty in the NPI Registry, under taxonomy code 207RC0000X. Dr. Haque is board certified in cardiovascular disease by the American Board of Internal Medicine. Dmand AI has Dr. Haque's licenses on file in 3 states: California, Illinois and Massachusetts.

Dmand AI lists angioplasty, cardiac catheterization, endocarditis and pacemaker or defibrillator implantation among the conditions Dr. Haque treats.

CMS data shows 5,602 Medicare services from Dr. Haque across 36 procedure codes in 2024, for 1,784 Medicare patients. Medicare paid $401,722 for them.

CMS counts 1,784 Medicare patients who saw Dr. Haque in 2024. The largest group is 75 to 84, with 756 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 18% are also on Medicaid. Their average risk score is 1.73, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Haque's median patient age at 69, with 50% women.

In 2024, Dr. Haque wrote 4,175 Medicare Part D claims for 688 patients. 79% of them were for generic drugs. CMS names the drug for 3,910 of them, across 50 drugs with 11 or more claims each, at $1,030,940 in total drug cost. In 2023, CMS named 4,358 claims across 55 drugs.

Dr. Haque accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Haque as offering telehealth. CMS counts 16 procedures of coronary angioplasty and stenting by Dr. Haque, more than 42% of the clinicians it reports for that procedure.

Pacemaker insertion or repair: 1 to 10 procedures (CMS shows small counts as a range)

CMS Open Payments shows 357 general payments to Dr. Haque from 41 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 50% of the total. Abbott Laboratories paid the most, $25,352.

Dmand AI lists 1 award for Dr. Haque, most recently CMS Stage 1 EHR in 2013.

Dr. Haque graduated from Penn State College of Medicine in 2003. Dr. Haque is a member of ACC.

Dr. Haque is in network with 13 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. Medicare plans come from the most carriers, 10. Check the plan with the practice before a visit.